- Home
- TRVI vs RMM Comparison
TRVI vs RMM Comparison
Compare TRVI & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- RMM
- Stock Information
- Founded
- TRVI 2011
- RMM 2019
- Country
- TRVI United States
- RMM United States
- Employees
- TRVI N/A
- RMM N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- RMM Trusts Except Educational Religious and Charitable
- Sector
- TRVI Health Care
- RMM Finance
- Exchange
- TRVI Nasdaq
- RMM Nasdaq
- Market Cap
- TRVI 341.4M
- RMM 294.1M
- IPO Year
- TRVI 2019
- RMM N/A
- Fundamental
- Price
- TRVI $4.24
- RMM $14.95
- Analyst Decision
- TRVI Strong Buy
- RMM
- Analyst Count
- TRVI 8
- RMM 0
- Target Price
- TRVI $9.31
- RMM N/A
- AVG Volume (30 Days)
- TRVI 454.6K
- RMM 66.5K
- Earning Date
- TRVI 03-19-2025
- RMM 01-01-0001
- Dividend Yield
- TRVI N/A
- RMM 7.33%
- EPS Growth
- TRVI N/A
- RMM N/A
- EPS
- TRVI N/A
- RMM 0.96
- Revenue
- TRVI N/A
- RMM N/A
- Revenue This Year
- TRVI N/A
- RMM N/A
- Revenue Next Year
- TRVI N/A
- RMM N/A
- P/E Ratio
- TRVI N/A
- RMM $15.55
- Revenue Growth
- TRVI N/A
- RMM N/A
- 52 Week Low
- TRVI $1.39
- RMM $12.32
- 52 Week High
- TRVI $4.68
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- TRVI 60.00
- RMM 49.14
- Support Level
- TRVI $3.81
- RMM $14.79
- Resistance Level
- TRVI $4.04
- RMM $15.05
- Average True Range (ATR)
- TRVI 0.25
- RMM 0.13
- MACD
- TRVI -0.00
- RMM 0.03
- Stochastic Oscillator
- TRVI 90.89
- RMM 58.95
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.